Stabilitech, U.S. Department of Defense infectious news

Stabilitech received a three-year contract from the DoD's Defense Threat Reduction Agency (DTRA) worth up to $4 million to use the biotech's vaccine stabilization technology to stabilize adenovirus-ve...